Corporate information
Official name
Armo BioSciences Inc
Company type
Late-stage immuno-oncology company.Funding rounds
Series C-1 USD 67,000,000
USD 67,000,000 ( )
"The Series C-1 proceeds will be used to initiate phase 2/3 studies with ARMO’s lead immunotherapy agent AM0010 in non-small cell lung cancer and renal cell cancer and to support an ongoing pivotal phase 3 clinical trial in advanced pancreatic cancer. The
Investor | Profile | Country | Notes | |
---|---|---|---|---|
![]() |
Qiming Venture Partners | Initial investment. Led the round. | ||
![]() |
Decheng Capital (德诚资本) | Initial investment. | ||
![]() |
Quan Capital Ltd | Alternative investment firm with a focus on control-oriented investments in small- and medium-sized enterprises. | Initial investment. | |
![]() |
RTW Investments | Initial investment. | ||
![]() |
Sequoia Capital Operations LLC (Sequoia) | Venture capital firm. | Initial investment. | |
![]() |
Celgene Corp | Biopharmaceutical company committed to improving the lives of patients worldwide. | Follow-on investment. | |
![]() |
Clough Capital Partners LP | Follow-on investment. | ||
![]() |
Duff Ackerman & Goodrich Ventures (DAG Ventures) | A mid-stage venture capital partnership with a service-oriented mindset. | Follow-on investment. | |
![]() |
GV. | The venture capital arm of Alphabet Inc. (Formerly Google Ventures.) | Follow-on investment. | |
![]() |
HBM Healthcare Investments | Follow-on investment. | ||
![]() |
Kleiner Perkins Caufield & Byers LLC (KPCB) | Venture capital firm. | Follow-on investment. | |
![]() |
NanoDimension Inc (ND Capital) | Follow-on investment. | ||
![]() |
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. | Follow-on investment. |
Investment activity status
Active investor